Stock Earnings
Century Therapeutics Inc (IPSC) rating initates by Rodman & Renshaw
Century Therapeutics Inc’s filing revealed that its Chief Operations Officer Farid Adrienne unloaded Company’s shares for reported $1267.0 on Nov
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.